Brenus Pharma Raises €22.2 Million ($25 Million) to Advance Cancer Vaccine Trials

Sep 19, 2024, 08:13 AM

Brenus Pharma, a French biotech company based in Lyon, has successfully raised €22.2 million ($25 million) in a Series A funding round. The funds will be used to accelerate the clinical trials of its precision cancer vaccines. The funding round was led by Angelor, a prominent investment firm. Brenus Pharma specializes in developing innovative cancer vaccines aimed at improving patient outcomes.